342O Intracranial administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in recurrent glioblastoma (rGB): A multi-cohort adaptive phase I clinical trial. - Neyns, B.; Schwarze, J.K.; Bertels, C.; Geens, W.; Tijtgat, J.; Awada, G.; Vaeyens, F.; Cras, L.; Vanbinst, A-M.; Everaert, H.; Michotte, A.; Bruneau, M.; et al. (Annals of Oncology, 2021)